BioElectronics Corp. Appoints Charles Gregoire de Rothschild to Post
of Special Adviser to Board
FREDERICK, MD -- (MARKET WIRE) -- 05/26/09 -- BioElectronics Corp.
(PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free
anti-inflammatory devices, today announced the appointment of
international financier Charles Gregoire de Rothschild to the role of
Special Adviser to the Company's board of directors. Mr. de
Rothschild will support BioElectronics' continuing global expansion
efforts by leveraging his extensive domestic and international
financial expertise.
"I am a strong believer in BioElectronics Corporation's drug-free
pain relieving and healing products and see strong revenue and profit
growth over the coming years," commented Mr. de Rothschild. "I look
forward to helping the Company obtain the capital to allow movement
of these exciting products into the mainstream of medical
technologies and in assisting in the expansion of worldwide marketing
and distribution."
"We are excited to be working with Mr. de Rothschild toward the goals
of expanding our capital base and acquiring additional international
distribution partnerships. We believe his proven track record as a
highly successful financier for growth companies, in addition to his
strong international contacts, will allow BioElectronics to move a
step closer to our goal of worldwide distribution for our advanced
solutions for pain management and healing."
Mr. de Rothschild, Chairman of GDR Privee, an international
investment boutique, has an extensive international banking
background
and has served in many advisory roles.
About BioElectronics Corporation
BioElectronics Corporation is the maker of ActiPatch(R) Therapy,
RecoveryRx(TM) Devices, HealFast(TM) Therapy
(www.healfasttherapy.com) and the Allay(TM) family of inexpensive,
disposable drug-free anti-inflammatory devices. For more information
please see http://www.BioElectronicsCorp.com.
For media enquiries, please contact:
Joe Noel
BioElectronics Corp.
(925) 922-2560
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.